Goto, Hideki http://orcid.org/0000-0001-8361-9973
Kitawaki, Toshio
Fujii, Nobuharu
Kato, Koji
Onishi, Yasushi
Fukuhara, Noriko
Yamauchi, Takuji
Toratani, Kazunori
Kobayashi, Hiroki
Yoshida, Shota
Shimo, Masatoshi
Onodera, Koichi
Senjo, Hajime
Onozawa, Masahiro
Hirata, Kenji
Yokota, Isao
Teshima, Takanori
Article History
Received: 21 December 2022
Accepted: 28 March 2023
First Online: 18 April 2023
Declarations
:
: H.G. has received honoraria from Bristol-Myers Squibb, Eisai, Janssen, Chugai, Novartis, SymBio, Kyowa-Kirin, Astellas, MSD and Daiichi-Sankyo; and has received research grants from Bristol-Myers Squibb and Kyowa-Kirin; and has received research funding from Kyowa-Kirin, AbbVie and Chugai. T.K. has received honoraria from Novartis, Otsuka, Bristol-Myers Squibb, Chugai, SymBio and Asahi Kasei. N.F. has received honoraria from Novartis, Chugai, Daiichi-Sankyo, Nippon Shinyaku, Janssen, Pfizer and Astellas. K.K. has received honoraria from Novartis, Chugai and Kyowa-Kirin; and has received research funding from Chugai, Takeda, Kyowa-Kirin, AbbVie, Novartis, Eisai, Janssen, Bristol-Myers Squibb, Ono and Daiichi-Sankyo. Y.O. has received honoraria from Novartis, Pfizer, Janssen, AbbVie, Chugai, Bristol-Myers Squibb, Amgen, Kyowa-Kirin, SymBio, Astellas, MSD, Meiji Seika; and has received research funding from Novartis, Pfizer, Janssen and Takara Bio. N.F. has received honoraria from AstraZeneca, Bristol-Myers Squibb, Chugai, CLS Behring, Dainippon Sumitomo, Eisai, Janssen, Kyowa-Kirin, Nippon Shinyaku, Novartis, Ono, Otsuka, Sanofi, SymBio, Takeda and Zenyaku; and has received research funding from Bayer, Chugai, Celgene, Genmab and Incyte. K.O. has received honoraria from Novartis, AbbVie, Astellas, Janssen and Nippon Shinyaku; and has received research funding from Bristol-Myers Squibb, Celgene and Agois. T.Y., K.T., H.K., S.Y., M.S., H.S. M.O. and K.H. declare no competing interests. I.Y. has received grants from KAKENHI, AMED and Health, Labor and Welfare Policy Research Grants; and has received research funding from Nippon Medi-Physis; and has received honoraria from Chugai, Astra Zeneca and Nippon-Shinyaku. T.T. has received honoraria from Merck Sharp and Dohme, Takeda, Kyowa-Kirin, Bristol-Myers Squibb and Pfizer; and has received research funding from Chugai, Kyowa-Kirin, Sanofi, Astellas, TEIJIN PHARMA, Novartis, Fuji Pharma and Nippon Shinyaku; and served on an advisory board for Takeda and Novartis; and has participated in manuscript preparation as other financial interests for Janssen and Novartis.